LAVA Therapeutics NV Other Current Liabilities

LAVA Therapeutics NV (LVTX) currently reports a other current liabilities of $-32M as of September 2025. That compares with $6.3M in the prior-year period — down 618.7% year over year. Use the charts on this page to explore LAVA Therapeutics NV's other current liabilities history and peer comparisons.

LAVA Therapeutics NV's other current liabilities decreased from $6.3M to $-32M — a 618.7% year-over-year decrease (period ending September 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

LAVA Therapeutics NV reported $-32M in other current liabilities as of September 2025. That compares with $6.3M in the prior-year period — down 618.7% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current other current liabilities of $-32M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for LAVA Therapeutics NV, and consider following LVTX for alerts when major investors trade the stock.

LAVA Therapeutics NV is classified in the Healthcare sector. On other current liabilities, it currently shows $-32M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing LVTX with unrelated industries.